{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T07:12:30Z","timestamp":1769670750182,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nmd.2020.06.001","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T11:00:57Z","timestamp":1591527657000},"page":"546-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mutation spectrum and health status in skeletal muscle channelopathies in Japan"],"prefix":"10.1016","volume":"30","author":[{"given":"Ryogen","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Nakaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori P.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.06.001_bib0001","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/j.2040-4603.2015.tb00630.x","article-title":"Channelopathies of skeletal muscle excitability","volume":"5","author":"Cannon","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.nmd.2020.06.001_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/awp294","article-title":"The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment","volume":"133","author":"Matthews","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2020.06.001_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/brain\/awh639","article-title":"The primary periodic paralyses: diagnosis, pathogenesis and treatment","volume":"129","author":"Venance","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2020.06.001_bib0004","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3988\/jcn.2012.8.3.212","article-title":"Clinical characteristics and analysis of CLCN1 in patients with &quot;EMG Disease&quot","volume":"8","author":"Nam","year":"2012","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.nmd.2020.06.001_bib0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/19336950.2015.1075676","article-title":"Myotonia congenita: novel mutations in CLCN1 gene","volume":"9","author":"Liu","year":"2015","journal-title":"Channels"},{"key":"10.1016\/j.nmd.2020.06.001_bib0006","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1468-1331.2010.02992.x","article-title":"Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases","volume":"17","author":"Sansone","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2020.06.001_bib0007","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1468-1331.2012.03751.x","article-title":"Measuring quality of life impairment in skeletal muscle channelopathies","volume":"19","author":"Sansone","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2020.06.001_bib0008","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/brain\/awt133","article-title":"Non-dystrophic myotonia: prospective study of objective and patient reported outcomes","volume":"136","author":"Trivedi","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2020.06.001_bib0009","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.2012.12607","article-title":"Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial","volume":"308","author":"Statland","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.nmd.2020.06.001_bib0010","unstructured":"Exome Aggregation Consortium n.d. http:\/\/exac.broadinstitute.org\/."},{"key":"10.1016\/j.nmd.2020.06.001_bib0011","unstructured":"American College of Medical Genetics and Genomics n.d. https:\/\/www.acmg.net\/ACMG\/Medical-Genetics-Practice-Resources\/Practice-Guidelines.aspx."},{"key":"10.1016\/j.nmd.2020.06.001_bib0012","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","article-title":"Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.nmd.2020.06.001_bib0013","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/01.wnl.0000257819.47628.41","article-title":"Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL)","volume":"68","author":"Vincent","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mus.26071","article-title":"Validation of the individualized neuromuscular quality of life in Japanese patients with myotonic dystrophy","volume":"58","author":"Fujino","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.06.001_bib0015","first-page":"61","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"10.1016\/j.nmd.2020.06.001_bib0016","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.nmd.2020.06.001_bib0017","first-page":"316","article-title":"Compound heterozygous mutations in the muscle chloride channel gene (CLCN1) in a Japanese family with Thomsen's disease","volume":"53","author":"Sasaki","year":"2013","journal-title":"Clin Neurol"},{"key":"10.1016\/j.nmd.2020.06.001_bib0018","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.47.4.993","article-title":"Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita","volume":"47","author":"Zhang","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0019","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1212\/WNL.50.4.1176","article-title":"Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance","volume":"50","author":"Plassart-Schiess","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0020","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1212\/WNL.0b013e31827595e2","article-title":"New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics","volume":"79","author":"Raheem","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0021","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.ejhg.5200736","article-title":"Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia","volume":"9","author":"Sun","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2020.06.001_bib0022","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.53.2.297","article-title":"Founder mutations and the high prevalence of myotonia congenita in northern Finland","volume":"53","author":"Papponen","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0023","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4103\/0028-3886.72163","article-title":"Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita","volume":"58","author":"Gao","year":"2010","journal-title":"Neurol India"},{"key":"10.1016\/j.nmd.2020.06.001_bib0024","first-page":"1325","article-title":"Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia","volume":"57","author":"Meyer-Kleine","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2020.06.001_bib0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1097-4598(200103)24:3<357::AID-MUS1006>3.0.CO;2-E","article-title":"A novel CLCN1 mutation: P480T in a Japanese family with Thomsen's myotonia congenita","volume":"24","author":"Sasaki","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.06.001_bib0026","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2011.03.002","article-title":"A CLCN1 mutation in dominant myotonia congenita impairs the increment of chloride conductance during repetitive depolarization","volume":"494","author":"Tsujino","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nmd.2020.06.001_bib0027","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4196\/kjpp.2017.21.4.439","article-title":"Electrophysiological characteristics of R47W and A298T mutations in CLC-1 of myotonia congenita patients and evaluation of clinical features","volume":"21","author":"Chin","year":"2017","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.nmd.2020.06.001_bib0028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/19336950.2016.1212140","article-title":"Sequence CLCN1 and SCN4A in patients with Nondystrophic myotonias in Chinese populations: genetic and pedigree analysis of 10 families and review of the literature","volume":"11","author":"Yang","year":"2017","journal-title":"Channels"},{"key":"10.1016\/j.nmd.2020.06.001_bib0029","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.nmd.2008.01.007","article-title":"Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians","volume":"19","author":"Dupr\u00e9","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.06.001_bib0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.nmd.2018.03.006","article-title":"Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands","volume":"28","author":"Stunnenberg","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.06.001_bib0031","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1212\/WNL.0b013e31828cf8d0","article-title":"Prevalence study of genetically defined skeletal muscle channelopathies in England","volume":"80","author":"Horga","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0032","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/j.nmd.2016.06.400","article-title":"Prevalence study of muscle channelopathies in Italy","volume":"26","author":"Maggi","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.06.001_bib0033","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/humu.21501","article-title":"A mutation in a rare type of intron in a sodium-channel gene results in aberrant splicing and causes myotonia","volume":"32","author":"Kubota","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2020.06.001_bib0034","first-page":"388","article-title":"A Case of myotonia permanens with a variant in SCN4A gene","volume":"42","author":"Kibe","year":"2010","journal-title":"No to Hattatsu"},{"key":"10.1016\/j.nmd.2020.06.001_bib0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jns.2016.08.030","article-title":"A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes","volume":"369","author":"Kato","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2020.06.001_bib0036","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.nmd.2014.06.439","article-title":"Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia","volume":"24","author":"Furby","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.06.001_bib0037","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/01.wnl.0000342387.65477.46","article-title":"Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis","volume":"72","author":"Matthews","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0038","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.57.7.1323","article-title":"Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK","volume":"57","author":"Davies","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.06.001_bib0039","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/brain\/124.6.1091","article-title":"Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A","volume":"124","author":"Sternberg","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2020.06.001_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mus.23245","article-title":"Quality of life and measures of quality of life in patients with neuromuscular disorders","volume":"46","author":"Burns","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.06.001_bib0041","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12910-016-0132-2","article-title":"Using digital technologies to engage with medical research: views of myotonic dystrophy patients in Japan","volume":"17","author":"Coathup","year":"2016","journal-title":"BMC Med Ethics"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620301383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620301383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:45Z","timestamp":1760774985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620301383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0960896620301383"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.06.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutation spectrum and health status in skeletal muscle channelopathies in Japan","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}